Neuralink Raises $650 million Series E

Neuralink raised $650M in Series E financing. Neuralink secured $650 million in Series E funding to expand patient access to its brain-computer interface technology and develop new devices. The funding will support advancements in brain interface.

What it does

Neuralink secured $650 million in Series E funding to expand patient access to its brain-computer interface technology and develop new devices. The funding will support advancements in brain interface. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

The funding round is the clearest current traction signal available for Neuralink in the source bundle. Additional customer, revenue, and growth metrics can be layered in as source coverage expands.

Trend impact

Neuralink's round adds a current private-market signal to Healthcare & Life Sciences. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.

Funding history

• Recent · Series E · $650 million · undisclosed investors
• May 1, 2025 · Venture Round · $600 million · Various private investors
• June 1, 2023 · Series C · $205 million · Various

Products & services

• Healthcare & Life Sciences workflow monitoring tied to the funding announcement
• Customer-facing product described on the company website
• Operational tooling for healthcare & life sciences teams
• Data capture and reporting across core business processes
• Team expansion support funded by the latest round